Skip to main content

Carl Hull, Gregory Schiffman

Carl Hull, formerly vice president and general manager of Applied Biosystems’ Sequence Detection System and Microarray business units, has joined Gen-Probe as executive vice president and COO.
Prior to ABI, Hull was CEO at Applied Imaging and he worked in marketing and sales at Ventana Medical Systems and at Abbott Laboratories.


Former Affymetrix CFO Gregory Schiffman has joined the board of directors of Entelos. Schiffman is CFO at Dendreon. He also was a vice president and controller for Applied Biosystems and a manager at Hewlett Packard and at IBM.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.